Drug price regulation

Abstract : Drug prices are regulated in a legal framework that organizes the negotiation between pharmaceutical firms and a third-party payer responsible for healthcare reimbursement. This regulation aims at compensating for market failures associated with drug specificities. Explicit economic reasoning through the socalled health technology assessment framework is increasingly embedded in the institutional and administrative process of the evaluation procedure leading to market access, pricing and reimbursement for new drugs.
Type de document :
Chapitre d'ouvrage
Alain Marciano, Giovanni Battista Ramello. Encyclopedia of Law and Economics, Springer Science+Business Media LLC 2017, pp.1-8, 2017, 978-1-4614-7883-6. 〈10.1007/978-1-4614-7883-6_714-1〉. 〈https://link.springer.com/referenceworkentry/10.1007%2F978-1-4614-7883-6_714-1〉
Liste complète des métadonnées

https://halshs.archives-ouvertes.fr/halshs-01615092
Contributeur : Anne L'Azou <>
Soumis le : mercredi 11 octobre 2017 - 22:54:06
Dernière modification le : mardi 5 juin 2018 - 10:14:16

Identifiants

Citation

Jean-Michel Josselin, Laurie Rachet Jacquet, Véronique Raimond, Lise Rochaix. Drug price regulation. Alain Marciano, Giovanni Battista Ramello. Encyclopedia of Law and Economics, Springer Science+Business Media LLC 2017, pp.1-8, 2017, 978-1-4614-7883-6. 〈10.1007/978-1-4614-7883-6_714-1〉. 〈https://link.springer.com/referenceworkentry/10.1007%2F978-1-4614-7883-6_714-1〉. 〈halshs-01615092〉

Partager

Métriques

Consultations de la notice

156